I-MAB • IMAB
I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Rajkumar Kannan$145.3M
Market Cap • 23/04/20242016
(há 8 anos)
2020
(4 years ago)
NASDAQ
Listagem
Shanghai
318
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IMABSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.